Efficacy of Magnesium Supplementation on Glycemic Control in Type 2 Diabetes Patients: A Meta-Analysis
Keywords:
diabetes, magnesium, supplementation, glycemic control, meta-analysisAbstract
Objectives. To evaluate if magnesium supplementation, in addition to standard therapy, improves fasting blood sugar (FBS) and/or glycosylated hemoglobin (HbA1c) in patients with type 2 diabetes mellitus (T2DM) compared to placebo or other comparator.
Methodology. We searched MEDLINE/PubMed, Cochrane Library, Acta Medica Philippina, Health Research and Development Information Network (HERDIN) and references of reviewed journals from 1966 to July 2015 using the following search terms: “magnesium” OR “magnesium supplementation” OR “magnesium replacement”, AND randomized controlled trial AND diabetes OR diabetes mellitus OR non-insulin dependent diabetes mellitus OR diabetic OR diab* (with MeSH, where available). Studies were retrieved and rated independently using the standards provided by The Cochrane Collaboration. High quality trials were included in a systematic review and meta-analysis.
Results. Of the 689 records screened, 10 studies were included in the qualitative synthesis and 7 studies in the meta-analysis. Pooled data showed a non-significant trend towards improvement in glycemic control in the magnesium-treated group (mean difference -0.19, CI -0.58 to 0.21). There was a stronger but still non-significant trend in T2DM patients with hypomagnesemia (mean difference -1.16, CI -2.92 to 0.6).
Conclusion. Routine magnesium supplementation for improvement in glycemic control in T2DM patients cannot be recommended based on data from included studies in this meta-analysis.
Downloads
References
International Diabetes Federation. IDF Diabetes Atlas, 7th ed. Brussels, Belgium:
International Diabetes Federation, 2015. http://www.diabetesatlas.org. Accessed January 1, 2016.
Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC, United States of America: National Academies Press (US), 1997. https://www.ncbi.nlm.nih.gov/books/NBK109829/.
Yajnik CS, Smith RF, Hockaday TD, Ward NI. Fasting plasma magnesium concentrations and glucose disposal in diabetes. Br Med J (Clin Res Ed). 1984;288:1032-4. https://doi.org/10.1136/bmj.288.6423.1032.
Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension. 1993;21(6 Pt 2):1024-9. https://doi.org/10.1161/01.HYP.21.6.1024.
Moshfegh A, Goldman J, Ahuja, Rhodes D, LaComb R. What we eat in America, NHANES 2005–2006: Usual nutrient intakes from food and water compared to 1997 dietary reference intakes for vitamin D, calcium, phosphorus, and magnesium. Washington, DC: Department of Agriculture, Agricultural Research Service; 2009. Accessed October 13, 2015.
Chutia H, Lynrah KG. Association of serum magnesium deficiency with insulin resistance in type 2 diabetes mellitus. J Lab Physicians. 2015;7(2):75-8. https://doi.org/10.4103/0974-2727.163131.
Paolisso G, Passariello N, Pizza G, Marrazzo G, Giunta R, Sgambato S, et al. Dietary magnesium supplements improve B-cell response to glucose and arginine in elderly non-insulin dependent diabetic subjects. Acta Endocrinol (Copenh). 1989;121(1):16-20. https://doi.org/10.1530/acta.0.1210016.
Paolisso G, Sgambato S, Pizza G, Passariello N, Varricchio M, D’Onofrio F. Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diabetes Care 1989;12(4):265-9. https://doi.org/10.2337/diacare.12.4.265.
Paolisso G, Sgambato S, Gambardella A, et al. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr. 1992;55(6):1161-7.
Paolisso G, Scheen A, Cozzolino D, et al. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly non-insulin dependent (type II) diabetic patients. J Clin Endocrinol Metab. 1994;78(6):1510-4. https://doi.org/10.1210/jcem.78.6.8200955.
Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: A meta-analysis of randomised double-blind controlled trials. Diabet Med. 2006;23(10):1050-6. PMID: 16978367. https://doi.org/10.1111/j.1464-5491.2006.01852.x.
Simmons D, Joshi S, Shaw J. Hypomagnesaemia is associated with diabetes: Not pre-diabetes, obesity or the metabolic syndrome. Diabetes Res Clin Pract. 2010;87(2): 261-6. https://doi.org/10.1016/j.diabres.2009.11.003.
Sinha S, Sen S. Status of zinc and magnesium levels in type 2 diabetes mellitus and its relationship with glycemic status. Int J Diabetes Dev Ctries. 2014;34(4):220-3. https://doi.org/10.1007/s13410-014-0196-9.
Huerta MG, Roemmich JN, Kington ML et al. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care. 2005;28(5):1175-81. https://doi.org/10.2337/diacare.28.5.1175.
Barbagallo M and Dominguez LJ. Magnesium and type 2 diabetes: An Update. Int J Diabetes Clin Res 2015;2(1):019. https://doi.org/10.23937/2377-3634/1410019.
Larsson SC, Wolk A. Magnesium intake and risk of type 2 diabetes: A meta-analysis. J Intern Med. 2007;262(2):208-14. https://doi.org/10.1111/j.1365-2796.2007.01840.x.
Chaudhary DP, Sharma R, Bansal DD. Implications of magnesium deficiency in type 2 diabetes: A review. Biol Trace Elem Res. 2010;134(2):119-29. https://doi.org/10.1007/s12011-009-8465-z.
Tosiello L. Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med. 1996;156(11):1143-8. PMID: 8639008.
Khan LA, Alam AM, Ali L et al. Serum and urinary magnesium in young diabetic subjects in Bangladesh. Am J Clin Nutr. 1999;69(1):70-3.
Xu J, Xu W, Yao H, Sun W, Zhou Q, Cai L. Associations of serum and urinary magnesium with the pre-diabetes, diabetes and diabetic complications in the Chinese Northeast Population. PLoS One. 2013;8(2):e56750. https://doi.org/10.1371/journal.pone.0056750.
Kumari R. Role of magnesium as hypoglycemic agent in type 2 diabetes mellitus. J Evid Based Med Health. 2016;3(7):216-7. https://doi.org/10.18410/jebmh/2016/50.
Cahill F, Shahidi M, Shea J et al. High dietary magnesium intake is associated with low insulin resistance in the Newfoundland population. PLoS One. 2013;8(3): e58278. https://doi.org/10.1371/journal.pone.0058278.
Wang J, Persuitte G, Olendzki BC et al. Dietary magnesium intake improves insulin resistance among non-diabetic individuals with metabolic syndrome participating in a dietary trial. Nutrients. 2013;5(10):3910-9. https://doi.org/10.3390/nu5103910.
Schulze MB, Schulz M, Heidemann C et al. Fiber, magnesium intake and incidence of type 2 diabetes. Arch Intern Med. 2007;167(9):956-65.
Dong JY, Xun P, He K, Qin LQ. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care. 2011;34(9):2116-22. https://doi.org/10.2337/dc11-0518.
de Lourdes Lima M, Cruz T, Pousada JC, Rodrigues LE, Barbosa K, Canguçu V. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care. 1998;21(5):682-6. https://doi.org/10.2337/diacare.21.5.682.
de Valk HW, Verkaaik R, van Rijn HJ, Geerdink RA, Struyvenberg A. Oral magnesium supplementation in insulin-requiring type 2 diabetic patients. Diabetic Med 1998;15(6):503-7. https://doi.org/10.1002/(SICI)1096-9136(199806)15:6<503::AID-DIA596>3.0.CO;2-M.
Eriksson J, Kohvakka A. Magnesium and ascorbic acid supplementation in diabetes mellitus. Ann Nutr Metab 1995;39(4):217-23. PMID: 8546437.
Evert AB, Boucher JL, Cypress M et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2013;36(11):3821-42. https://doi.org/10.2337/dc13-2042.
Rodríguez-Morán M, Simental Mendia LE, Zambrano Galván G, Guerrero-Romero F. The role of magnesium in type 2 diabetes: a brief based-clinical review. Magnes Res. 2011;24(4):156-62. http://doi.org/10.1684/mrh.2011.0299.
Navarrete-Cortes A, Ble-Castillo JL, Guerrero-Romero F, Cordova-Uscanga R, Juarez-Rojop, Aguilar-Mariscal Hidemi, et al. No effect of magnesium supplementation on metabolic control and insulin sensitivity in type 2 diabetic patients with normomagnesemia. Magnesium Research. 2014;27(2):48-56. PMID: 25204013. https://doi.org/10.1684/mrh.2014.0361.
Food and Nutrition Research Institute. Recommended Daily Intake of Macronutrients, Vitamins and Minerals in the Philippines. Taguig City, Philippines: Food and Nutrition Research Institute, Department of Science and Technology, 2015. http://www.fnri.dost.gov.ph/index.php/159-fnri-launches-the-philippine-dietary-reference-intakes-pdri-2015. Accessed December 2, 2015.
World Health Organization and Food and Agriculture Organization of the United Nations. Vitamin and Mineral Requirements in Human Nutrition, 2nd ed. Rome, Italy: Food and Agriculture Organization of the United Nations, 2004. http://apps.who.int/iris/bitstream/10665/42716/1/9241546123.pdf.
Eibl NL, Kopp HP, Nowak HR, Schnack CJ, Hopmeier PG, Schernthaner G., Hypomagnesemia in type II diabetes: Effect of a 3-month replacement therapy. Diabetes Care. 1995;18(2):188-92. PMID: 7729296.
Gullestad L, Jacobsen T, Dolva., Effect of magnesium treatment on glycemic control and metabolic parameters in NIDDM patients. Diabetes Care. 1994;17(5):460-1. PMID: 8062622.
Published
How to Cite
Issue
Section
License
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.
